2013 Fiscal Year Final Research Report
Mechanism of action of a novel STAT3 inhibitor and its effect on leukemic stem cell
Project/Area Number |
23591381
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Nagoya University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Keywords | STAT阻害剤 / 分子標的薬 / ヒト化マウス |
Research Abstract |
STAT proteins are transcription factors that mediate cell proliferation and differentiation. Aberrant signals of STAT are strongly involved in cancer. We demonstrated that a novel STAT inhibitor, OPB-31121, strongly inhibited STAT3 and STAT5 phosphorylation, and induced significant growth inhibition in various hematopoietic malignant cells. OPB-31121 was particularly effective against leukemia harboring BCR-ABL, FLT3/ITD, and JAK2 V617F. We showed the significant anti-tumor effect of OPB-31121 against human leukemia cells using patient-derived xenograft model.
|
Research Products
(9 results)